Holen Sie sich die Stockscreener-App
22.68
1.56%
-0.36
Vorhandelsmarkt:
23.08
0.40
+1.76%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$23.04
Offen:
$22.88
24-Stunden-Volumen:
893.62K
Relative Volume:
0.87
Marktkapitalisierung:
$1.31B
Einnahmen:
$2.25B
Nettoeinkommen (Verlust:
$-1.18B
KGV:
-1.096
EPS:
-20.6926
Netto-Cashflow:
$19.92M
1W Leistung:
-6.24%
1M Leistung:
+0.84%
6M Leistung:
-25.07%
1J Leistung:
-29.24%
1-Tages-Spanne:
$22.54
$23.16
1-Wochen-Bereich:
$22.51
$25.03
52-Wochen-Spanne:
$21.00
$36.82
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
22.68 | 1.33B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-17 | Fortgesetzt | William Blair | Outperform |
| 2026-01-06 | Eingeleitet | BTIG Research | Buy |
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now? - AOL.com
What's Driving the Recent Buzz Around Enovis (ENOV) Stock - Kavout
Enovis (ENOV) Earnings Date and Reports 2026 - MarketBeat
Earnings Preview: Enovis Corp to Report Financial Results Pre-market on May 07 - Moomoo
A Look At Enovis (ENOV) Valuation After ESOP Shelf Registration For Up To 3,650,000 Shares - simplywall.st
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now? - The Motley Fool
ENOV Reiterated by BTIG -- Price Target Maintained at $39.00 - GuruFocus
Enovis (ENOV) earnings expected to grow: What to know ahead of next week's release - MSN
A Look at Enovis Corp (ENOV) After 7.1% Decline -- GF Value $49. - GuruFocus
Enovis (ENOV) director Rajiv Vinnakota receives 9,346-share equity grant - Stock Titan
Enovis (ENOV) director Liam Kelly receives grant of 9,346 common shares - Stock Titan
Enovis shareholders approve amendment to 2020 incentive plan at annual meeting - Investing.com Nigeria
Enovis Shareholders Approve Expanded Incentive Plan and Board - TipRanks
Enovis (NYSE: ENOV) investors back 2020 incentive plan share and pay changes - Stock Titan
Is Enovis’ Improving Q1 2026 Results And Reaffirmed Outlook Altering The Investment Case For ENOV? - simplywall.st
Small-Cap Stock Picks: Hims & Hers Buy, Enovis & LifeStance Sell | May 2026News and Statistics - IndexBox
Does Enovis (ENOV) have the potential to rally 65.45% as Wall Street analysts expect? - MSN
Enovis (ENOV) CFO has 7,774 shares withheld to cover taxes - Stock Titan
Enovis (ENOV) CEO McDonald has 12,634 shares withheld for RSU taxes - Stock Titan
Enovis (ENOV) Valuation Check After Reaffirmed 2026 Guidance And Solid First Quarter Results - simplywall.st
Enovis Q1 Growth And New Launches Refine Long Term Profit Story - Yahoo Finance
Earnings call transcript: Enovis Q1 2026 beats forecasts, stock fluctuates By Investing.com - Investing.com India
Does Enovis (ENOV) Have the Potential to Rally 65.45% as Wall Street Analysts Expect? - sharewise.com
Earnings call transcript: Enovis Q1 2026 beats forecasts, stock fluctuates - Investing.com
Enovis Corporation Q1 2026 earnings preview - MSN
Canaccord Genuity Keeps Their Buy Rating on Enovis (ENOV) - The Globe and Mail
Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump - simplywall.st
Enovis (ENOV) Is Up 16.3% After Reaffirming 2026 Outlook And Narrowing Losses – Has The Bull Case Changed? - Sahm
CCORF Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $50 - Moomoo
Enovis Corporation $ENOV Shares Sold by Vanguard Group Inc. - MarketBeat
Enovis Corporation 2026 Q1ResultsEarnings Call Presentation (NYSE:ENOV) 2026-05-10 - Seeking Alpha
Enovis Q1 Earnings Call Highlights - TradingView
Enovis Earnings Call Highlights Recon Strength, Caution - The Globe and Mail
A Quick Look at Today's Ratings for Enovis Corp(ENOV.US), With a Forecast Between $36 to $40 - Moomoo
Enovis (ENOV) Q1 2026 Earnings Transcript - AOL.com
Enovis Corporation (NYSE:ENOV) Q1 2026 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA), Enovis (ENOV) and Insmed (INSM) - The Globe and Mail
Enovis Is Maintained at Outperform by Evercore ISI Group - Moomoo
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):